skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8102

Biologics: Targets and Therapy

(1,101,176) Views

Editor in Chief Dr Doris Mangiaracina Benbrook

1177-5475

Rapid Communication
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick, Terry Diamond
Biologics: Targets and Therapy 2008, 2:161-163
26 March 2008

Review
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich, Boris Nohé
Biologics: Targets and Therapy 2008, 2:151-160
26 March 2008

Original Research
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz
Biologics: Targets and Therapy 2008, 2:143-149
26 March 2008

Review
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia Castellini
Biologics: Targets and Therapy 2008, 2:129-141
26 March 2008

Review
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
David A Schwartz
Biologics: Targets and Therapy 2008, 2:125-128
26 March 2008

Review
Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E Kalb
Biologics: Targets and Therapy 2008, 2:115-124
26 March 2008

Review
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie, Chien-Fu Hung, Richard Roden, T-C Wu
Biologics: Targets and Therapy 2008, 2:107-113
26 March 2008

Review
Sunitinib for advanced renal cell cancer
Chris Coppin
Biologics: Targets and Therapy 2008, 2:97-105
26 March 2008

Review
Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley, Andrew H Ko
Biologics: Targets and Therapy 2008, 2:83-95
26 March 2008

Review
Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki Okuda
Biologics: Targets and Therapy 2008, 2:75-82
26 March 2008

Review
Current and future applications of the anti-IgE antibody omalizumab
Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini
Biologics: Targets and Therapy 2008, 2:67-73
26 March 2008

Review
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Bella Kaufman, Steven Stein, Michelle A Casey, Beth O Newstat
Biologics: Targets and Therapy 2008, 2:61-65
25 March 2008

Review
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mary F Mulcahy
Biologics: Targets and Therapy 2008, 2:53-59
25 March 2008

Review
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi, Enrica Morra
Biologics: Targets and Therapy 2008, 2:41-52
25 March 2008

Review
Abciximab: a reappraisal of its use in coronary care
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, et al
Biologics: Targets and Therapy 2008, 2:29-39
25 March 2008

Review
Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano, Sagar Lonial
Biologics: Targets and Therapy 2008, 2:13-27
25 March 2008

Review
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Robert C Fang, Robert D Galiano
Biologics: Targets and Therapy 2008, 2:1-12
25 March 2008

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed